25 results
Breast Cancer Mammography Screening Decision Aid - Age 50–69

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 50–69 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
Breast Cancer Mammography Screening Decision Aid - Age 40–49

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 40–49 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
Breast Cancer Mammography Screening Decision Aid - Age 70–74

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Screening Decision Aid ... - Age 70–74 Canadian ... Task Force on Preventive ... #Diagnosis #PrimaryCare ... #Mammography #DecisionAid
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... Women with in HIV-AIDS ... Preventing First ... HumanPapillomavirus #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... to 5 mg/kg/day IV ... #Treatment #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... duration same as for treatment ... Disease Note: Treatment ... #Treatment #management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing Bacterial ... Bacterial #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... recommended for KS treatment ... #Treatment #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... 400 mg) PO or IV ... mucosal #IDSA #Prevention ... #Treatment #management